{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:47:19Z","timestamp":1789501639006,"version":"build-2803163510"},"reference-count":31,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Co-administration of vaccines can impact the immune response and safety. We aim to systematically review the current scientific literature and find evidence regarding the immunogenicity and safety of pneumococcal vaccines co-administered with common vaccines that are recommended for travelers, including hepatitis A, hepatitis B, yellow fever, tetanus, diphtheria, and acellular pertussis (Tdap), Japanese encephalitis, rabies, typhoid, or meningococcal (MCV) vaccine in adults (18 years or older). Methods: We followed the PRISMA 2020 guidelines and used the PICOS process to select the keywords. We searched PubMed, Web of Science, Scopus, EMBASE, and Google from 1 January 2000 to 30 June 2024. We included randomized controlled trials, non-randomized controlled trials, observational studies, case series, and case reports in adults, all published in English. Results: Out of 598 articles screened, 6 studies were included in our study. Three studies involved immunocompetent individuals, and three involved immunocompromised individuals. Co-administration of pneumococcal vaccine with Tdap or Hepatitis A in immunocompetent individuals was safe and immunogenic. Similar findings were reported for immunocompromised individuals when pneumococcal vaccines were co-administered with Tdap, hepatitis A, and hepatitis B. However, no reports investigated the co-administration of yellow fever, rabies, Japanese encephalitis, and typhoid. Two non-randomized studies in immunocompromised individuals had a high risk of bias. Conclusions: The studies collectively indicate that the co-administration of pneumococcal vaccines with Hepatitis A and Tdap vaccines in adult immunocompetent and immunocompromised individuals is safe and immunogenic. However, a knowledge gap remains, and further high-quality studies are needed, particularly due to the limited number of studies and the potential risk of bias.<\/jats:p>","DOI":"10.3390\/vaccines13060643","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T10:47:22Z","timestamp":1750070842000},"page":"643","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Raziyeh","family":"Niyati","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, North Zealand, 3400 Hiller\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-1904","authenticated-orcid":false,"given":"Omid","family":"Rezahosseini","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, North Zealand, 3400 Hiller\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ekenberg","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, North Zealand, 3400 Hiller\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten Schade","family":"Larsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, 8200 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5552-0095","authenticated-orcid":false,"given":"Zitta Barrella","family":"Harboe","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, North Zealand, 3400 Hiller\u00f8d, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, 2200 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination Greatly Reduces Disease, Disability, Death and Inequity Worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"taad085","DOI":"10.1093\/jtm\/taad085","article-title":"Travel Vaccines\u2014Priorities Determined by Incidence and Impact","volume":"30","author":"Steffen","year":"2023","journal-title":"J. Travel Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.mayocp.2019.02.025","article-title":"Vaccines for International Travel","volume":"94","author":"Freedman","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.amjmed.2020.02.005","article-title":"The Pretravel Consultation: Recent Updates","volume":"133","author":"Murray","year":"2020","journal-title":"Am. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"tax046","DOI":"10.1093\/jtm\/tax046","article-title":"What Proportion of International Travellers Acquire a Travel-Related Illness? A Review of the Literature","volume":"24","author":"Angelo","year":"2017","journal-title":"J. Travel Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijregi.2023.03.002","article-title":"Travel Demographics, Patterns, and Plans among Adult Nordic Travelers","volume":"7","author":"Larsen","year":"2023","journal-title":"IJID Reg."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ecarnot, F., Maggi, S., Michel, J.-P., Veronese, N., and Rossanese, A. (2021). Vaccines and Senior Travellers. Front. Aging, 2.","DOI":"10.3389\/fragi.2021.677907"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2195786","DOI":"10.1080\/21645515.2023.2195786","article-title":"Vaccine Co-Administration in Adults: An Effective Way to Improve Vaccination Coverage","volume":"19","author":"Bonanni","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2477300","DOI":"10.1080\/07853890.2025.2477300","article-title":"Age-Related Changes in the Immune System and Challenges for the Development of Age-Specific Vaccines","volume":"57","author":"Doherty","year":"2025","journal-title":"Ann. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/21645515.2015.1091908","article-title":"Interactions of Conjugate Vaccines and Co-Administered Vaccines","volume":"12","author":"Findlow","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rezahosseini, O., Bazargan, A., Eiberg, M.F., Korsgaard, A.P., and Harboe, Z.B. (2025, June 06). Safety and Immunogenicity of Coadministration of Herpes Zoster Vaccines with Other Vaccines in Adults. Available online: https:\/\/osf.io\/n7s63\/.","DOI":"10.3390\/vaccines13060637"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127293","DOI":"10.1016\/j.vaccine.2025.127293","article-title":"Immunogenicity and Adverse Effects of Pneumococcal Vaccines Co-Administered with Influenza or SARS-CoV-2 Vaccines in Adults: A Systematic Review and Meta-Analysis","volume":"59","author":"Rahimi","year":"2025","journal-title":"Vaccine"},{"key":"ref_14","unstructured":"Niyati, R., Rezahosseini, O., Ekenberg, C., Larsen, C.S., and Harboe, Z.B. (2025, January 11\u201315). Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review. Proceedings of the ESCMID Global, Vienna, Austria."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A Tool for Assessing Risk of Bias in Non-Randomised Studies of Interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.cmi.2023.08.006","article-title":"Coadministered Pneumococcal Conjugate Vaccine Decreases Immune Response to Hepatitis A Vaccine: A Randomized Controlled Trial","volume":"29","author":"Riekkinen","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1016\/j.vaccine.2016.10.020","article-title":"Effect of Tdap When Administered before, with or after the 13-Valent Pneumococcal Conjugate Vaccine (Coadministered with the Quadrivalent Meningococcal Conjugate Vaccine) in Adults: A Randomised Controlled Trial","volume":"34","author":"Tashani","year":"2016","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Song, J.Y., Cheong, H.J., Noh, J.Y., Choi, M.J., Yoon, J.G., Lee, S.N., Kang, S.H., Jeong, E.J., Jo, Y.M., and Kim, W.J. (2018). Immunogenicity and Safety of a Tetanus-Diphtheria Vaccine and a 13-Valent Pneumococcal Conjugate Vaccine after Concomitant Vaccination in\u2009\u2265\u200950-Year-Old Adults. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3479-9"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-019-1883-1","article-title":"Evaluation of Pneumococcal and Tetanus Vaccine Responses in Patients with Rheumatoid Arthritis Receiving Baricitinib: Results from a Long-Term Extension Trial Substudy","volume":"21","author":"Winthrop","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/1060028019839650","article-title":"Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis","volume":"53","author":"Mogul","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1016\/j.vaccine.2021.04.052","article-title":"Primary Vaccination in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation\u2014A Single Center Retrospective Efficacy Analysis","volume":"39","author":"Sattler","year":"2021","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbmt.2017.12.795","article-title":"Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance","volume":"24","author":"Palazzo","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2710.2008.00920.x","article-title":"Lenalidomide in the Treatment of Multiple Myeloma: A Review","volume":"33","author":"Armoiry","year":"2008","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_25","first-page":"100812","article-title":"Pneumococcal Serotypes and Risk Factors in Adult Community Acquired Pneumonia 2018\u201320: A Multicentre UK Cohort Study","volume":"37","author":"Lansbury","year":"2024","journal-title":"Lancet Reg. Health\u2013Eur."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Luck, J.N., Tettelin, H., and Orihuela, C.J. (2020). Sugar-Coated Killer: Serotype 3 Pneumococcal Disease. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.613287"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e00084-18","DOI":"10.1128\/CMR.00084-18","article-title":"Factors That Influence the Immune Response to Vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"tax006","DOI":"10.1093\/jtm\/tax006","article-title":"Tetanus\u2013Diphtheria\u2013Pertussis Vaccine May Suppress the Immune Response to Subsequent Immunization with Pneumococcal CRM197-Conjugate Vaccine (Coadministered with Quadrivalent Meningococcal TT-Conjugate Vaccine): A Randomized, Controlled Trial\u22c6","volume":"24","author":"Tashani","year":"2017","journal-title":"J. Travel Med."},{"key":"ref_29","unstructured":"Orenstein, W., Offit, P., Edwards, K.M., and Plotkin, S. (2023). Chapter 16\u2014Combination Vaccines. Plotkin\u2019s Vaccines (Eighth Edition), Elsevier."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41541-024-00874-4","article-title":"Insights into Vaccines for Elderly Individuals: From the Impacts of Immunosenescence to Delivery Strategies","volume":"9","author":"Hou","year":"2024","journal-title":"NPJ Vaccines"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"taw001","DOI":"10.1093\/jtm\/taw001","article-title":"Travel-Related Health Risks in Moderately and Severely Immunocompromised Patients: A Case-Control Study\u2020","volume":"23","author":"Dekkiche","year":"2016","journal-title":"J. Travel Med."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/6\/643\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:51:55Z","timestamp":1760032315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/6\/643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["vaccines13060643"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13060643","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]}}}